Clinical Laboratory Division, National Cancer Center Hospital, Japan.
Lung Cancer. 2011 Jun;72(3):309-15. doi: 10.1016/j.lungcan.2010.09.013. Epub 2010 Oct 30.
Primary adenocarcinoma with signet-ring cell component (Ad-SRCC) of the lung has been well characterized clinicopathologically and histologically, but their genetics has rarely been investigated. A recent report suggesting an association between Ad-SRCC and EML4-ALK fusion prompted us to undertake a histological, immunohistochemical, and molecular analysis of 10 cases of primary Ad-SRCC identified out of 699 lung adenocarcinomas (1.4%). Most of the Ad-SRCCs showed characteristic architectural as well as cytological features including cohesive clustering of signet-ring cells, a solid/acinar growth pattern, and alveolar filling at the tumor periphery. Diffuse co-expression of TTF-1 and p63 was observed in half of the Ad-SRCCs, and this immunoprofile has not been recognized previously. Four Ad-SRCCs (40%) harbored ALK translocations detected by reverse-transcriptase polymerase chain reaction, fluorescence in situ hybridization, and immunohistochemistry. One new EML4-ALK fusion variant was identified. One ALK-rearranged tumor showed focal squamous differentiation. None of the present Ad-SRCCs had EGFR or KRAS mutations, regardless of ALK status. This study successfully utilized tumor histology alone to identify a subset of adenocarcinomas showing a high rate of ALK translocation. The characteristic histology, immunoprofile, frequent ALK translocation, and total lack of EGFR or KRAS mutations, may suggest that Ad-SRCC forms a histologically/molecularly coherent subgroup of adenocarcinoma.
肺原发性腺癌伴印戒细胞成分(Ad-SRCC)在临床病理和组织学上已有很好的特征描述,但它们的遗传学研究却很少。最近有报道提示 Ad-SRCC 与 EML4-ALK 融合之间存在关联,这促使我们对 699 例肺腺癌中确定的 10 例原发性 Ad-SRCC 进行组织学、免疫组织化学和分子分析(占 1.4%)。大多数 Ad-SRCC 表现出特征性的结构和细胞学特征,包括印戒细胞的聚集性簇状、实性/腺泡生长模式以及肿瘤边缘的肺泡填充。半数的 Ad-SRCC 观察到 TTF-1 和 p63 的弥漫共表达,这一免疫表型以前尚未被认识。通过逆转录聚合酶链反应、荧光原位杂交和免疫组织化学检测到 4 例 Ad-SRCC(40%)存在 ALK 易位。鉴定出一种新的 EML4-ALK 融合变体。一个 ALK 重排肿瘤显示局灶性鳞状分化。无论 ALK 状态如何,目前的 Ad-SRCC 均无 EGFR 或 KRAS 突变。本研究成功地仅利用肿瘤组织学来鉴定出一组具有高 ALK 易位率的腺癌。其特征性组织学、免疫表型、频繁的 ALK 易位以及完全缺乏 EGFR 或 KRAS 突变,可能提示 Ad-SRCC 形成了一种在组织学/分子上具有一致性的腺癌亚群。